MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B

Yan Nan Shen, In Seon Bae, Gil-Hong Park, Hwa Sik Choi, Kee Ho Lee, Sang Hoon Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gastric cancer is characterized by resistance to ionizing radiation. The development of resistance to radiotherapy in gastric cancer patients is one of the obstacles to effective radiotherapy. MicroRNAs are small well-conserved non-coding RNA species that regulate post-transcriptional activation. Our study aimed to investigate the role of miR-196b in radiation-induced gastric cancer. In the present study, we found that miR-196b expression was significantly reduced following radiation. The ectopic miR-196b expression sensitized SNU-638 gastric cancer cells and increased γ-H2AX foci upon radiation treatment. Bioinformatics analysis suggested that the DNA repair protein RAD23B was a putative target gene of miR-196b. Overexpression of miR-196b suppressed RAD23B expression in SNU-638 cells. Reporter assays further showed that miR-196b inhibited RAD23B 3′-UTR luciferase activity. Knockdown of RAD23B by small interfering RNA transfection closely mimicked the outcomes of miR-196b transfection, leading to impaired DNA damage repair in gastric cancer cells. Our results show that miR-196b improved radiosensitivity of SNU-638 cells by targeting RAD23B. Our data indicate that miR-196b is a potential target to enhance the effect of radiation treatment on gastric cancer cells. These findings will provide evidence for a new therapeutic target in radiotherapy.

Original languageEnglish
Pages (from-to)362-369
Number of pages8
JournalBiomedicine and Pharmacotherapy
Volume105
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Radiation Tolerance
MicroRNAs
Stomach Neoplasms
Radiotherapy
DNA Repair
Transfection
Radiation-Induced Neoplasms
Radiation
Untranslated RNA
Radiation Effects
3' Untranslated Regions
Ionizing Radiation
Computational Biology
Luciferases
Small Interfering RNA
Transcriptional Activation
DNA Damage
Therapeutics
Genes
Proteins

Keywords

  • Gastrointestinal cancer cells
  • Ionizing radiation
  • MicroRNA
  • RAD23B
  • Radiosensitivity

ASJC Scopus subject areas

  • Pharmacology

Cite this

MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B. / Shen, Yan Nan; Bae, In Seon; Park, Gil-Hong; Choi, Hwa Sik; Lee, Kee Ho; Kim, Sang Hoon.

In: Biomedicine and Pharmacotherapy, Vol. 105, 01.09.2018, p. 362-369.

Research output: Contribution to journalArticle

Shen, Yan Nan ; Bae, In Seon ; Park, Gil-Hong ; Choi, Hwa Sik ; Lee, Kee Ho ; Kim, Sang Hoon. / MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B. In: Biomedicine and Pharmacotherapy. 2018 ; Vol. 105. pp. 362-369.
@article{7cc3a6ed5f764224ad82102ac784d340,
title = "MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B",
abstract = "Gastric cancer is characterized by resistance to ionizing radiation. The development of resistance to radiotherapy in gastric cancer patients is one of the obstacles to effective radiotherapy. MicroRNAs are small well-conserved non-coding RNA species that regulate post-transcriptional activation. Our study aimed to investigate the role of miR-196b in radiation-induced gastric cancer. In the present study, we found that miR-196b expression was significantly reduced following radiation. The ectopic miR-196b expression sensitized SNU-638 gastric cancer cells and increased γ-H2AX foci upon radiation treatment. Bioinformatics analysis suggested that the DNA repair protein RAD23B was a putative target gene of miR-196b. Overexpression of miR-196b suppressed RAD23B expression in SNU-638 cells. Reporter assays further showed that miR-196b inhibited RAD23B 3′-UTR luciferase activity. Knockdown of RAD23B by small interfering RNA transfection closely mimicked the outcomes of miR-196b transfection, leading to impaired DNA damage repair in gastric cancer cells. Our results show that miR-196b improved radiosensitivity of SNU-638 cells by targeting RAD23B. Our data indicate that miR-196b is a potential target to enhance the effect of radiation treatment on gastric cancer cells. These findings will provide evidence for a new therapeutic target in radiotherapy.",
keywords = "Gastrointestinal cancer cells, Ionizing radiation, MicroRNA, RAD23B, Radiosensitivity",
author = "Shen, {Yan Nan} and Bae, {In Seon} and Gil-Hong Park and Choi, {Hwa Sik} and Lee, {Kee Ho} and Kim, {Sang Hoon}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.biopha.2018.05.111",
language = "English",
volume = "105",
pages = "362--369",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B

AU - Shen, Yan Nan

AU - Bae, In Seon

AU - Park, Gil-Hong

AU - Choi, Hwa Sik

AU - Lee, Kee Ho

AU - Kim, Sang Hoon

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Gastric cancer is characterized by resistance to ionizing radiation. The development of resistance to radiotherapy in gastric cancer patients is one of the obstacles to effective radiotherapy. MicroRNAs are small well-conserved non-coding RNA species that regulate post-transcriptional activation. Our study aimed to investigate the role of miR-196b in radiation-induced gastric cancer. In the present study, we found that miR-196b expression was significantly reduced following radiation. The ectopic miR-196b expression sensitized SNU-638 gastric cancer cells and increased γ-H2AX foci upon radiation treatment. Bioinformatics analysis suggested that the DNA repair protein RAD23B was a putative target gene of miR-196b. Overexpression of miR-196b suppressed RAD23B expression in SNU-638 cells. Reporter assays further showed that miR-196b inhibited RAD23B 3′-UTR luciferase activity. Knockdown of RAD23B by small interfering RNA transfection closely mimicked the outcomes of miR-196b transfection, leading to impaired DNA damage repair in gastric cancer cells. Our results show that miR-196b improved radiosensitivity of SNU-638 cells by targeting RAD23B. Our data indicate that miR-196b is a potential target to enhance the effect of radiation treatment on gastric cancer cells. These findings will provide evidence for a new therapeutic target in radiotherapy.

AB - Gastric cancer is characterized by resistance to ionizing radiation. The development of resistance to radiotherapy in gastric cancer patients is one of the obstacles to effective radiotherapy. MicroRNAs are small well-conserved non-coding RNA species that regulate post-transcriptional activation. Our study aimed to investigate the role of miR-196b in radiation-induced gastric cancer. In the present study, we found that miR-196b expression was significantly reduced following radiation. The ectopic miR-196b expression sensitized SNU-638 gastric cancer cells and increased γ-H2AX foci upon radiation treatment. Bioinformatics analysis suggested that the DNA repair protein RAD23B was a putative target gene of miR-196b. Overexpression of miR-196b suppressed RAD23B expression in SNU-638 cells. Reporter assays further showed that miR-196b inhibited RAD23B 3′-UTR luciferase activity. Knockdown of RAD23B by small interfering RNA transfection closely mimicked the outcomes of miR-196b transfection, leading to impaired DNA damage repair in gastric cancer cells. Our results show that miR-196b improved radiosensitivity of SNU-638 cells by targeting RAD23B. Our data indicate that miR-196b is a potential target to enhance the effect of radiation treatment on gastric cancer cells. These findings will provide evidence for a new therapeutic target in radiotherapy.

KW - Gastrointestinal cancer cells

KW - Ionizing radiation

KW - MicroRNA

KW - RAD23B

KW - Radiosensitivity

UR - http://www.scopus.com/inward/record.url?scp=85047834230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047834230&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2018.05.111

DO - 10.1016/j.biopha.2018.05.111

M3 - Article

C2 - 29864624

AN - SCOPUS:85047834230

VL - 105

SP - 362

EP - 369

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -